Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Warning over lack of women taking part in drug trials

  • Comment
Women are underrepresented in European drug trials despite differences in the effectiveness of treatments, say public health researchers.

Women are underrepresented in European drug trials despite differences in the effectiveness of treatments, say public health researchers.

The researchers from the department of public health at the University of Alicante in Spaincriticise the European Medicines Agency, the body responsible for licensing drugs and approving drug trials in Europe, for failing to develop gender specific guidelines or strategies.

They say although theagency acknowledges that drugs may act differently in men and women, it has resisted providing separate guidelines for drug trials for reasons that are unclear.

They argue that Europe should follow the US where the law requires a quota of women to be included in clinical trials.

Journal of Epidemiology and Community Health (2006) 60:911-913.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.